| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.5M | +4217.3% |
| Cost of Revenue | $1.5M | +23.9% |
| Gross Profit | $1.1M | +193.6% |
| R&D Expense | $154K | -92.1% |
| SG&A Expense | $11.2M | -24.0% |
| Operating Income | -$56.5M | -56.8% |
| Pre-tax Income | -$59.7M | -59.6% |
| Income Tax | -$1.0M | -8199.7% |
| Net Income | -$58.7M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $26K | -82.8% |
| Inventory | $64K | -82.4% |
| Current Assets | $950K | -83.7% |
| Total Assets | $28.2M | -67.8% |
| Current Liabilities | $18.3M | +6.4% |
| Total Liabilities | $18.6M | -15.1% |
| Stockholders' Equity | $8.5M | +252.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.5M | +22.7% |
| Capital Expenditures | $28K | +762.8% |
| Investing Cash Flow | -$28K | +99.7% |
| Financing Cash Flow | $6.7M | +551.5% |
| Free Cash Flow | -$10.5M | +22.5% |
| -56.9% |
| EPS (Basic) | -$21.45 | -879.5% |
| EPS (Diluted) | -$21.45 | -879.5% |